Sponsored Symposia Overview

Tuesday 19 October | 13:00-14:00 Mozambique time


Gender Equity in Health:  Female genital schistosomiasis – a major challenge for Women’s Health in Sub-Saharan Africa

Medicines for Malaria Venture (MMV)

Main post-approval and real-life studies conducted and ongoing in parallel with the launch and scale-up of Pyramax in Africa 

Instituto de Salud Carlos III (ISCIII)

Fostering a stronger collaboration in Personalised medicine: The EU-Africa PerMed project 

European Global Health Research Institutes Network (EGHRIN)

Equal Voices: Addressing Inequities in Global Health Research Participation 

Wednesday 20 October | 13:00-14:00 Mozambique time

Amsterdam Institute for Global Health and Development (PAVIA) & Karolinska Institutet (PROFORMA) 

Equity in safety: improving pharmacovigilance of drugs and vaccines in Africa

Barcelona Institute for Global Health (ISGlobal) 

Advances in Intermittent Preventive Treatment of malaria in infants (IPTi) for improved and equitable health for children under 2 in sub-Saharan Africa 

Drugs for Neglected Diseases initiative (DNDi)

Addressing equity challenges in health for neglected populations 

Deutsche Stiftung Weltbevölkerung (DSW)

Advocacy challenges and opportunities for stepping up support for poverty-related and neglected disease R&D after COVID-19 

The European & Developing Countries Clinical Trials Partnership

The EDCTP2 programme is supported under Horizon 2020, the European Union’s Framework Programme for Research & Innovation.

© Copyright 2021 EDCTP